Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3969 results

Sort By:

Does a Virtual Program for Pelvic Pain Improve Pain and Sexual Outcomes in Individuals With Provoked Vestibulodynia?

Study ID: NCT06999395
Start Date: 2025-07
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

250

Intervention / Treatment

Virtual online pelvic health program

Sponsor

Queen's University

Source: clinicaltrials.gov

Share:
Add to list

Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)

Study ID: NCT06868914
Start Date: 2025-06-24
End Date: 2028-01-13
Study Type

Interventional

Study Phase

Phase1

No. of Participants

35

Intervention / Treatment

TMS (Magventure Magpro 100 With Magoption)

Sponsor

National Institute on Drug Abuse (NIDA)

Source: clinicaltrials.gov

Share:
Add to list

SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

Study ID: NCT07021495
Start Date: 2025-06-30
End Date: 2029-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

840

Intervention / Treatment
Sponsor

Leiden University Medical Center

Source: clinicaltrials.gov

Share:
Add to list

An Open, Parallel-group, Randomized, Medical Device Study to Assess the Usability and Performance of Surgify HaloTM in Spine Surgery Versus State-of-art (Rosen Burr)

Study ID: NCT06827795
Start Date: 2025-06-30
End Date: 2025-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

A burr used in spine surgery

Sponsor

Surgify Medical Oy

Source: clinicaltrials.gov

Share:
Add to list

A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer

Study ID: NCT07027514
Start Date: 2025-08-15
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

60

Intervention / Treatment

Tolododekin Alfa

Cetrelimab

Sponsor

Ankyra Therapeutics, Inc

Source: clinicaltrials.gov

Share:
Add to list

Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma

Study ID: NCT06045195
Start Date: 2025-08
End Date: 2029-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Pembrolizumab

Sponsor

University of Cologne

Source: clinicaltrials.gov

Share:
Add to list

Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes

Study ID: NCT06820281
Start Date: 2025-12-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Tirzepatide 2.5mg weekly

Placebo injection (normal saline)

Sponsor

Garvan Institute of Medical Research

Source: clinicaltrials.gov

Share:
Add to list

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Study ID: NCT06807281
Start Date: 2025-11-03
End Date: 2032-02-22
Study Type

Interventional

Study Phase

Phase3

No. of Participants

500

Intervention / Treatment

Abrocitinib

Sponsor

Pfizer

Source: clinicaltrials.gov

Share:
Add to list

Real World Environmental Exposure Study With Healthy and Cystic Fibrosis Subjects

Study ID: NCT06339450
Start Date: 2025-09-01
End Date: 2027-11-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

16

Intervention / Treatment

walk tours

Sponsor

CRETEIL Intercommunal Hospital Center

Source: clinicaltrials.gov

Share:
Add to list

Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression

Study ID: NCT07001995
Start Date: 2025-10-01
End Date: 2028-10-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

leden

etoposide and carboplatin

Sponsor

Hunan Province Tumor Hospital

Source: clinicaltrials.gov

Share:
Add to list